189 related articles for article (PubMed ID: 27337454)
1. Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae.
Mathers A
Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337454
[TBL] [Abstract][Full Text] [Related]
2. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.
Saïdani M; Hammami S; Kammoun A; Slim A; Boutiba-Ben Boubaker I
J Med Microbiol; 2012 Dec; 61(Pt 12):1746-1749. PubMed ID: 22918869
[TBL] [Abstract][Full Text] [Related]
3. KPC and NDM-1 genes in related Enterobacteriaceae strains and plasmids from Pakistan and the United States.
Pesesky MW; Hussain T; Wallace M; Wang B; Andleeb S; Burnham CA; Dantas G
Emerg Infect Dis; 2015 Jun; 21(6):1034-7. PubMed ID: 25988236
[TBL] [Abstract][Full Text] [Related]
4. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
5. The threat of carbapenem-resistant bacteria in the environment: Evidence of widespread contamination of reservoirs at a global scale.
Mills MC; Lee J
Environ Pollut; 2019 Dec; 255(Pt 1):113143. PubMed ID: 31541827
[TBL] [Abstract][Full Text] [Related]
6. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
Bou G; Vila J; Seral C; Castillo FJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
[TBL] [Abstract][Full Text] [Related]
7. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
8. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
Logan LK; Weinstein RA
J Infect Dis; 2017 Feb; 215(suppl_1):S28-S36. PubMed ID: 28375512
[TBL] [Abstract][Full Text] [Related]
9. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
10. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
11. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
[TBL] [Abstract][Full Text] [Related]
12. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Demir Y; Zer Y; Karaoglan I
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
[TBL] [Abstract][Full Text] [Related]
13. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
14. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
15. The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey.
Karabay O; Altindis M; Koroglu M; Karatuna O; Aydemir ÖA; Erdem AF
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():6. PubMed ID: 26860360
[TBL] [Abstract][Full Text] [Related]
16. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
17. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
18. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology.
El-Herte RI; Kanj SS; Matar GM; Araj GF
J Infect Public Health; 2012 Jun; 5(3):233-43. PubMed ID: 22632597
[TBL] [Abstract][Full Text] [Related]
19. Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014.
Dortet L; Cuzon G; Ponties V; Nordmann P
Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205502
[TBL] [Abstract][Full Text] [Related]
20. Environmental Spread of New Delhi Metallo-β-Lactamase-1-Producing Multidrug-Resistant Bacteria in Dhaka, Bangladesh.
Islam MA; Islam M; Hasan R; Hossain MI; Nabi A; Rahman M; Goessens WHF; Endtz HP; Boehm AB; Faruque SM
Appl Environ Microbiol; 2017 Aug; 83(15):. PubMed ID: 28526792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
